In contrast, high mRNA expression of RhoB significantly correlated with poor prognosis for HER2-positive/EGFRlow breast cancer patients (Fig 5E; P < 0.0001, high: n = 14, low: n = 96). This evidence concerns the gene ERBB2 and breast carcinoma.